These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32156809)

  • 21. Combination Adjuvants Enhance Recombinant Protein Vaccine Protection against Fungal Infection.
    Wüthrich M; Dobson HE; Ledesma Taira C; Okaa UJ; Dos Santos Dias L; Isidoro-Ayza M; Petrovsky N; Klein BS
    mBio; 2021 Aug; 12(4):e0201821. PubMed ID: 34399628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the immune response and evaluation of the protective capacity of rSsnA against Streptococcus suis infection in pigs.
    Gómez-Gascón L; Cardoso-Toset F; Tarradas C; Gómez-Laguna J; Maldonado A; Nielsen J; Olaya-Abril A; Rodríguez-Ortega MJ; Luque I
    Comp Immunol Microbiol Infect Dis; 2016 Aug; 47():52-9. PubMed ID: 27477507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccine.
    O'Donnell JS; Isaacs A; Jakob V; Lebas C; Barnes JB; Reading PC; Young PR; Watterson D; Dubois PM; Collin N; Chappell KJ
    Front Immunol; 2022; 13():976968. PubMed ID: 36119058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of various adjuvants on efficacy of a vaccine against Streptococcus bovis and Lactobacillus spp in cattle.
    Shu Q; Hillard MA; Bindon BM; Duan E; Xu Y; Bird SH; Rowe JB; Oddy VH; Gill HS
    Am J Vet Res; 2000 Jul; 61(7):839-43. PubMed ID: 10895910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a recombinant fusion protein vaccine formulation to protect against Streptococcus pyogenes.
    Morefield G; Touhey G; Lu F; Dunham A; HogenEsch H
    Vaccine; 2014 Jun; 32(30):3810-5. PubMed ID: 24837509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of aluminium hydroxide on innate immunity and immunogenicity of bacterial and synthetic antigens of Streptococcus pneumoniae].
    Kurbatova EA; Akhmatov ÉA; Akhmatova NK; Vorob'ev DS; Egorova NB; Baturo AP; Romanenko ÉE; Tsvetkov IuE; Sukhova EV; Iashunskiĭ DV; Nifant'ev NÉ
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):59-67. PubMed ID: 25816515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant.
    Bielinska AU; O'Konek JJ; Janczak KW; Baker JR
    Vaccine; 2016 Jul; 34(34):4017-24. PubMed ID: 27317451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
    Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
    J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with recombinant Sao protein confers protection against Streptococcus suis infection.
    Li Y; Gottschalk M; Esgleas M; Lacouture S; Dubreuil JD; Willson P; Harel J
    Clin Vaccine Immunol; 2007 Aug; 14(8):937-43. PubMed ID: 17567767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.
    Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS
    PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new recombinant SsnA protein combined with aluminum hydroxide protects mouse against Streptococcus suis.
    Gómez-Gascón L; Cardoso-Toset F; Amarilla PS; Tarradas C; Carrasco L; Olaya-Abril A; Jiménez-Munguía I; Rodríguez-Ortega MJ; Luque I
    Vaccine; 2014 Dec; 32(51):6992-6999. PubMed ID: 25454868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Protective properties of certain external proteins of group B streptococci].
    Grabovskaia KB; Leont'eva GF; Meringova LF; Vorob'eva EI; Suvorov AN; Totolian A
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (5):44-50. PubMed ID: 18038546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination with novel immunostimulatory adjuvants against blood-stage malaria in mice.
    Su Z; Tam MF; Jankovic D; Stevenson MM
    Infect Immun; 2003 Sep; 71(9):5178-87. PubMed ID: 12933862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative study of experimental conjugated and combined vaccines against group B streptococci].
    Ditina MA; Meringova LF; Leont'eva GF; Frabovskaia KB; Yang A; Shen Z; Suvorov AN
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (1):37-41. PubMed ID: 19338234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg.
    Khajuria A; Gupta A; Malik F; Singh S; Singh J; Gupta BD; Suri KA; Suden P; Srinivas VK; Ella K; Qazi GN
    Vaccine; 2007 Jun; 25(23):4586-94. PubMed ID: 17498851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
    Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
    Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Semisynthetic, self-adjuvanting vaccine development: Efficient, site-specific sortase A-mediated conjugation of Toll-like receptor 2 ligand FSL-1 to recombinant protein antigens under native conditions and application to a model group A streptococcal vaccine.
    Xu Z; Rivera-Hernandez T; Chatterjee O; Walker MJ; Moyle PM
    J Control Release; 2020 Jan; 317():96-108. PubMed ID: 31758971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197.
    Caro-Aguilar I; Ottinger E; Hepler RW; Nahas DD; Wu C; Good MF; Batzloff M; Joyce JG; Heinrichs JH; Skinner JM
    Hum Vaccin Immunother; 2013 Mar; 9(3):488-96. PubMed ID: 23249976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.